https://ftasesignal.com/index.....php/co-evolution-bet
This article highlights a number of factors for labeling updates, including selecting priorities for updating; information sources and evidentiary requirements; plus the risks, challenges, and opportunities for iterative analysis to ensure recommending information for oncology medications continues to be highly relevant to existing clinical training. © 2019 The Authors. The Oncologist published by Wiley Periodicals, Inc. with respect to AlphaMed Press.BACK
Like
Comment
Share
